A detailed history of Avion Wealth transactions in Biogen Inc. stock. As of the latest transaction made, Avion Wealth holds 16 shares of BIIB stock, worth $3,101. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16
Previous 2 700.0%
Holding current value
$3,101
Previous $1,000 200.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$190.52 - $236.72 $2,667 - $3,314
14 Added 700.0%
16 $3,000
Q1 2024

May 03, 2024

BUY
$212.02 - $267.71 $424 - $535
2 New
2 $1,000
Q3 2023

Oct 20, 2023

SELL
$253.3 - $285.89 $759 - $857
-3 Reduced 18.75%
13 $2,000
Q2 2023

Jul 14, 2023

BUY
$275.25 - $318.06 $4,404 - $5,088
16 New
16 $4,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $27.9B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Avion Wealth Portfolio

Follow Avion Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avion Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Avion Wealth with notifications on news.